If you want to understand how a single gene can wreck the nervous system, start with the cell's recycling route. Neurons are absurdly long cells. They have to move cargo from the cell body down axons, clear worn-out material, and keep lysosomes working over distances that would be trivial in most other tissues. When that transport breaks, the damage does not stay local for long.
A new study identifies BORCS5 as one of those genes that quietly sits inside a basic cellular logistics system until it fails and everything starts backing up. The paper reports 16 affected people from nine families with bi-allelic BORCS5 variants and shows that the consequences range from devastating prenatal disease to progressive childhood neurodegeneration. The common thread is lysosomal dysfunction.
The Cellular Delivery System That Stops Delivering
BORCS5 encodes part of the BLOC-One-Related Complex, better known as BORC. This complex helps lysosomes move outward inside cells and supports their positioning and fusion. In neurons, that matters a lot. Lysosomes are not just trash bags. They are mobile repair and recycling units, and axons depend on them reaching the right place at the right time.
The new data show what happens when BORCS5 is knocked out or weakened. Patients with homozygous protein-truncating variants had the most severe phenotype: prenatally lethal arthrogryposis multiplex congenita, major brain malformations, and neuropathological evidence of neuroaxonal dystrophy. In other words, the nervous system was already badly compromised before birth.
People with missense or splice-site variants survived longer but still showed a heavy neurological burden. The reported features included microcephaly, developmental epileptic encephalopathy, optic atrophy, spasticity, and progressive movement disorders. Brain MRI added another layer: diffuse hypomyelination, corpus callosum abnormalities, and progressive global cerebral atrophy. That pattern points to a disorder that is both neurodevelopmental and neurodegenerative, which is a nasty combination because the brain starts from behind and keeps losing ground.
The Mechanism Is Not Just "The Lysosomes Moved Wrong"
The strongest part of the paper is that it does not stop at the clinical description. The authors pushed the story into animal and cell models to see what the variants were actually doing.
In zebrafish, borcs5 knockout caused microcephaly, motor deficits, and greater seizure susceptibility. That gives the human phenotype an independent experimental echo instead of leaving it as a one-family anecdote.
The induced pluripotent stem cell-derived neuron work is even more useful. Protein-truncating variants caused perinuclear lysosomal clustering and impaired lysosomal axonal trafficking in forebrain neurons. That is the traffic jam in plain view: the lysosomes pile up in the wrong place and fail to travel where neurons need them.
But the paper also shows the disease is not only about transport. Both truncating and missense variants were associated with reduced lysosomal proteolysis and reduced activity of lysosomal hydrolases including glucocerebrosidase and cathepsin B. That means even when the trafficking phenotype differs across variant classes, lysosomal function itself is still compromised. The cargo trucks are not just parked badly; the machinery inside them is underperforming too.
Why This Gene Matters Beyond a Rare Disorder
This is the kind of paper that matters because it sharpens an entire disease category. Neurology already has a long list of disorders where lysosomes are either directly mutated or secondarily impaired, but BORCS5 expands that map in an important way. It ties together organelle positioning, axonal transport, and lysosomal enzymatic failure in one gene with a wide clinical spectrum.
That spectrum is the real lesson. Complete loss of function appears compatible with only the most severe prenatal presentations, while partial disruption produces children who are born alive but accumulate neurological injury over time. Clinically, that should push geneticists to think of BORCS5 in cases that combine epilepsy, white matter abnormalities, optic involvement, and progressive motor decline. Biologically, it suggests that neurons can tolerate some disruption of the BORC system, but not enough to remain healthy forever.
It also reinforces a larger point in neuroscience: many brain disorders that look unrelated at the bedside are really failures of intracellular housekeeping. Myelin defects, seizures, developmental delay, and movement disorders can all emerge from the same deeper problem if the cell cannot move and process its own waste correctly.
The Bigger Picture
Rare disease papers often read like catalogs of misery. This one does more than that. It pinpoints a mechanism. BORCS5 is not merely associated with disease; it appears to sit in a critical control point for lysosomal movement and lysosomal performance. That gives future work something concrete to measure and, eventually, something concrete to target.
For now, the immediate takeaway is blunt: when lysosomes cannot travel and cannot digest properly, neurons pay twice. First they lose maintenance where it is needed most, and then they lose the ability to clear what is already breaking down. In the developing brain, that is enough to reshape an entire life before it properly begins.
References
- Mencacci, N. E., Minakaki, G., Maroofian, R., De Pace, R., Paimboeuf, A., Branco Fonseca, T., Abramova, T., Shannon, P., Chitayat, D., Magrinelli, F., Peng, W. J., Chatterjee, D., Eldessouky, S. H., Baptista, J., Marton, T., Vogt, J., Ortigoza-Escobar, J. D., Martorell, L., Gomez-Chiari, M., Wentzensen, I. M., Kamsteeg, E. J., Zaki, M. S., Scardamaglia, A., Zifarelli, G., Al-Hassnan, Z. N., Miller, E., Shinar, S., Matsa, L. S., Appikonda, S. H. C., Otaify, G. A., Al-Thihli, K., Al-Maawali, A., Schwake, M., Severino, M., Houlden, H., Patten, S. A., Bonifacino, J. S., Bhatia, K. P., Krainc, D. (2026). Pathogenic variants in BORCS5 cause a spectrum of neurodevelopmental and neurodegenerative disorders with lysosomal dysfunction. The Journal of Clinical Investigation. DOI: 10.1172/JCI195336
Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.